An open randomized controlled trial of desmopressin and pulse dexamethasone as adjunct therapy in patients with pulmonary involvement associated with severe leptospirosis

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1207-1212

  Niwattayakul, K ^a   Kaewtasi, S ^a   Chueasuwanchai, S ^b   Hoontrakul, S ^c   Chareonwat, S ^d   Suttinont, C ^e   Phimda, K ^f   Chierakul, W ^b   Silpasakorn, S ^g   Suputtamongkol, Y ^g  

^a Muang Loei Ram Hospital   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Chumphon Hospital   (Thailand)

^d Chaiyapoom Hospital   (Thailand)

^e MAHARAT NAKHON RATCHASIMA HOSPITAL   (Thailand)

^f Udon Thani Center Hospital   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Desmopressin; Dexamethasone; Leptospirosis; Pulmonary involvement

Indexed keywords

BILIRUBIN; DESMOPRESSIN; DEXAMETHASONE; PREDNISONE; ANTIINFLAMMATORY AGENT; ARGIPRESSIN[1 DEAMINO];

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; HEMOPTYSIS; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; LEPTOSPIROSIS; LUNG DISEASE; LUNG HEMORRHAGE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; MIDDLE AGED; SURVIVAL; THAILAND; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DEAMINO ARGININE VASOPRESSIN; DEXAMETHASONE; FEMALE; HUMANS; LEPTOSPIROSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955162592     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03037.x     Document Type: Article

References (19)

1. Bhati AR, Nally JE, Ricarldi JN. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003, 3:757-771.
2. Singh SS, Vijayachari P, Sinha A. Clinico-epidemiological study of hospitalized cases of severe leptospirosis. Indian J Med Res 1999, 109:94-99.
3. Marotto PC, Nascimento CM, Eluf-Neto J. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999, 29:1561-1563.
4. Yersin C, Bovet P, Merien F. Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles. Trans R Soc Trop Med Hyg 2000, 94:71-76.
5. Seijo A, Coto H, San Juan J. Lethal leptospiral pulmonary hemorrhage: an emerging disease in Buenos Aires, Argentina. Emerg Infect Dis 2002, 8:1004-1005.
6. Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 2002, 6:52-59.
7. Luks AM, Lakshminarayanan S, Hirschmann JV. Leptospirosis presenting as diffuse alveolar hemorrhage: case report and literature review. Chest 2003, 123:639-643.
8. Nally JE, Chantranuwat C, Wu XY. Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 2004, 164:1115-1127.
9. Yang GG, Hsu YH. Nitric oxide production and immunoglobulin deposition in leptospiral hemorrhagic respiratory failure. J Formos Med Assoc 2005, 104:759-763.
10. Trivedi SV, Chavda RK, Wadia PZ. Role of glucocorticoid pulse therapy in pulmonary involvement in leptospirosis. J Assoc Physicians India 2001, 49:901-903.
11. Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: an excellent response to bolus methyl prednisolone. Postgrad Med J 2006, 82:602-606.
12. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997, 90:2515-2521.
13. Pea L, Roda L, Boussaud V, Lonjon B. Desmopressin therapy for massive hemoptysis associated with severe leptospirosis. Am J Respir Crit Care Med 2003, 167:726-728.
14. Leptospira and leptospirosis 1999, Faine SBAdler BBolin CPerolat P. eds, 2nd edn, Melbourne, MediSci
15. Cheemaa PS, Srivastava SK, Amutha R. Detection of pathogenic leptospires in animals by PCR based on lipL21 and lipL32 genes. Indian J Exp Biol 2007, 45:568573.
16. La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997, 35:2715-2727.
17. Segura ER, Ganoza CA, Campos K. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantitation of leptospiral burden. Clin Infect Dis 2005, 40:343-351.
18. Ren SX, Fu G, Jiang XG. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003, 422:888-893.
19. Kaufmann JE, Oksche A, Wollheim CB. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 2000, 106:107-116.